✦ LIBER ✦

Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

✍ Scribed by Gurwith, Marc; Lock, Michael; Taylor, Eve M; Ishioka, Glenn; Alexander, Jeff; Mayall, Tim; Ervin, John E; Greenberg, Richard N; Strout, Cynthia; Treanor, John J; Webby, Richard; Wright, Peter F

Book ID: 120978648
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 315 KB
Volume: 13
Category: Article
ISSN: 1473-3099
DOI: 10.1016/S1473-3099(12)70345-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of 2009 pandem

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial

✍ Xiao-Feng Liang; Hua-Qing Wang; Jun-Zhi Wang; Han-Hua Fang; Jiang Wu; Feng-Cai Z 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 161 KB

Safety and immunogenicity of an inactiva

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial

✍ Jiangtao Lin; Jiansan Zhang; Xiaoping Dong; Hanhua Fang; Jiangting Chen; Nan Su; 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 135 KB

Evaluation of safety and immunogenicity

Evaluation of safety and immunogenicity of HNVAC, an MDCK-based H1N1 pandemic influenza vaccine, in Phase I single centre and Phase II/III multi-centre, double-blind, randomized, placebo-controlled, parallel assignment studies

✍ Basavaraj, V.H.; Sampath, G.; Hegde, Nagendra R.; Mohan, V. Krishna; Ella, Krish 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 320 KB

Safety and efficacy of the peptide-based

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial

✍ Pollard, Richard B; Rockstroh, Jürgen K; Pantaleo, Giuseppe; Asmuth, David M; Pe 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 458 KB

A phase 3, randomized, double-blind, pla

A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits

✍ Kuschner, Robert A.; Russell, Kevin L.; Abuja, Mary; Bauer, Kristen M.; Faix, De 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 845 KB

Safety and immunogenicity of SC599, an o

Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial

✍ Odile Launay; Christine Sadorge; Nathalie Jolly; Béatrice Poirier; Stéphane Béch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 795 KB